{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:21:41Z","timestamp":1788315701769,"version":"build-2803163510"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002780","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T17:24:58Z","timestamp":1555089898000},"page":"e1002780","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":55,"title":["Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1377-6273","authenticated-orcid":true,"given":"Masanori","family":"Kawasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0688-6618","authenticated-orcid":true,"given":"Carmenchu","family":"Echiverri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2254-4557","authenticated-orcid":true,"given":"Elizabeth","family":"Cadena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Reside","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Tarcela","family":"Gler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Higashiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyonori","family":"Katsuragi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3982-4176","authenticated-orcid":true,"given":"Yongge","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"key":"ref1","article-title":"Global tuberculosis report","year":"2018","journal-title":"Global tuberculosis report"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"MG Ghany","year":"2009","journal-title":"Hepatol Baltim Md"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.biotechadv.2010.06.004","article-title":"Advances in developing HIV-1 viral load assays for resource-limited settings","volume":"28","author":"S Wang","year":"2010","journal-title":"Biotechnol Adv"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1586\/17476348.2016.1166960","article-title":"Assessment of treatment response in tuberculosis","volume":"10","author":"N Rockwood","year":"2016","journal-title":"Expert Rev Respir Med"},{"key":"ref5","unstructured":"World Health Organization. Treatment of Tuberculosis: Guidelines [Internet]. 4th ed. 2010 [cited 2019 Mar 12]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK138748\/\" xlink:type=\"simple\">http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK138748\/<\/ext-link>"},{"key":"ref6","article-title":"WHO Treatment Guidelines for Drug-Resistant Tuberculosis","year":"2016","journal-title":"WHO Treatment Guidelines for Drug-Resistant Tuberculosis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(10)70003-7","article-title":"Biomarkers for tuberculosis disease activity, cure, and relapse","volume":"10","author":"RS Wallis","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"12345","DOI":"10.1016\/S0021-9258(18)67246-1","article-title":"Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli","volume":"261","author":"SW Hunter","year":"1986","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3349\/ymj.1990.31.4.333","article-title":"Production of monoclonal antibodies to lipoarabinomannan-B and use in the detection of mycobacterial antigens in sputum","volume":"31","author":"SN Cho","year":"1990","journal-title":"Yonsei Med J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1128\/JCM.30.9.2415-2418.1992","article-title":"Detection of lipoarabinomannan as a diagnostic test for tuberculosis","volume":"30","author":"E Sada","year":"1992","journal-title":"J Clin Microbiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1128\/JCM.38.6.2278-2283.2000","article-title":"Development of antigen detection assay for diagnosis of tuberculosis using sputum samples","volume":"38","author":"LM Pereira Arias-Bouda","year":"2000","journal-title":"J Clin Microbiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e9848","DOI":"10.1371\/journal.pone.0009848","article-title":"Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples","volume":"5","author":"K Dheda","year":"2010","journal-title":"PLoS ONE"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.5588\/ijtld.11.0614","article-title":"Diagnostic accuracy of induced sputum LAM ELISA for tuberculosis diagnosis in sputum-scarce patients","volume":"16","author":"JG Peter","year":"2012","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/glycob\/8.2.113","article-title":"Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects","volume":"8","author":"D Chatterjee","year":"1998","journal-title":"Glycobiology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1128\/JB.187.3.854-861.2005","article-title":"Characterization of a truncated lipoarabinomannan from the Actinomycete Turicella otitidis","volume":"187","author":"M Gilleron","year":"2005","journal-title":"J Bacteriol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"12380","DOI":"10.1074\/jbc.270.21.12380","article-title":"Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium","volume":"270","author":"KH Khoo","year":"1995","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nchembio.2571","article-title":"Covalent modifications of polysaccharides in mycobacteria","volume":"14","author":"SK Angala","year":"2018","journal-title":"Nat Chem Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jasms.2005.02.023","article-title":"Structural characterization of Lipoarabinomannans from Mycobacterium tuberculosis and Mycobacterium smegmatis by ESI mass spectrometry","volume":"16","author":"CJ Petzold","year":"2005","journal-title":"J Am Soc Mass Spectrom"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1021\/acschembio.6b01071","article-title":"Biosynthesis of the Methylthioxylose Capping Motif of Lipoarabinomannan in Mycobacterium tuberculosis","volume":"12","author":"SK Angala","year":"2017","journal-title":"ACS Chem Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"10281","DOI":"10.1038\/srep10281","article-title":"The diagnostic targeting of a carbohydrate virulence factor from M.Tuberculosis","volume":"5","author":"CE Chan","year":"2015","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e01338","DOI":"10.1128\/JCM.01338-18","article-title":"A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO\u2019s Performance Target for Tuberculosis Diagnosis","volume":"56","author":"GB Sigal","year":"2018","journal-title":"J Clin Microbiol"},{"key":"ref22","unstructured":"Clinical and Laboratory Standards Institute. EP12-A2: User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline\u2014Second Edition. 2008."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"CC Boehme","year":"2010","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study","volume":"377","author":"CC Boehme","year":"2011","journal-title":"Lancet"},{"key":"ref25","article-title":"Guidance for Industry: Pulmonary Tuberculosis: Developing Drugs for Treatment","year":"2013"},{"key":"ref26","article-title":"Addendum to the guideline on the evaluation of medicinal products indicated for treatment of bacterial infections","year":"2013"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tube.2013.12.002","article-title":"Time to positivity in liquid culture predicts colony forming unit counts of Mycobacterium tuberculosis in sputum specimens","volume":"94","author":"AH Diacon","year":"2014","journal-title":"Tuberc Edinb Scotl"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.5588\/ijtld.13.0063","article-title":"Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment","volume":"17","author":"CM Bark","year":"2013","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref29","unstructured":"Minister of Health, Labour and Welfare. Japanese Pharmacopoeia, Sixteenth Edition. 2011."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fneur.2015.00179","article-title":"A Practical Guide to Immunoassay Method Validation","volume":"6","author":"U Andreasson","year":"2015","journal-title":"Front Neurol"},{"key":"ref31","unstructured":"World Health Organization. Toman\u2019s tuberculosis: case detection, treatment and monitoring [Internet]. 2nd edition. 2004 [cited 2019 Mar 12]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/42701\/9241546034.pdf?sequence=1\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/42701\/9241546034.pdf?sequence=1<\/ext-link>"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1473-3099(06)70628-4","article-title":"International standards for tuberculosis care","volume":"6","author":"PC Hopewell","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1164\/rccm.201203-0444OC","article-title":"Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis","volume":"186","author":"KP Fennelly","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1164\/rccm.201103-0536OC","article-title":"A multisite assessment of the quantitative capabilities of the Xpert MTB\/RIF assay","volume":"184","author":"R Blakemore","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e28815","DOI":"10.1371\/journal.pone.0028815","article-title":"Comparison of quantitative techniques including Xpert MTB\/RIF to evaluate mycobacterial burden","volume":"6","author":"RN van Zyl-Smit","year":"2011","journal-title":"PLoS ONE"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-2600(13)70119-X","article-title":"Assessment of the sensitivity and specificity of Xpert MTB\/RIF assay as an early sputum biomarker of response to tuberculosis treatment","volume":"1","author":"SO Friedrich","year":"2013","journal-title":"Lancet Respir Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1128\/JCM.37.2.290-295.1999","article-title":"Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis","volume":"37","author":"TJ Hellyer","year":"1999","journal-title":"J Clin Microbiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/JCM.01526-09","article-title":"Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy","volume":"48","author":"L Li","year":"2010","journal-title":"J Clin Microbiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1128\/JCM.00547-11","article-title":"Molecular bacterial load assay, a culture-free biomarker for rapid and accurate quantification of sputum Mycobacterium tuberculosis bacillary load during treatment","volume":"49","author":"I Honeyborne","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/jac\/dku415","article-title":"The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations","volume":"70","author":"R Bowness","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tube.2016.03.001","article-title":"Serial image analysis of Mycobacterium tuberculosis colony growth reveals a persistent subpopulation in sputum during treatment of pulmonary TB","volume":"98","author":"DA Barr","year":"2016","journal-title":"Tuberc Edinb Scotl"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"949","DOI":"10.5588\/ijtld.10.0616","article-title":"Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients","volume":"15","author":"AH Diacon","year":"2011","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1128\/AAC.02243-12","article-title":"Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary tuberculosis","volume":"57","author":"AH Diacon","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref44","unstructured":"Center for Drug Evaluation and Research, Food and Drug Administration. LOI Decision Letter for the Qualification of Lipoarabinomannan as a Pharmacodynamic\/response Biomarker [Internet] [cited 2019 Mar 12]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.fda.gov\/downloads\/Drugs\/DevelopmentApprovalProcess\/DrugDevelopmentToolsQualificationProgram\/BiomarkerQualificationProgram\/UCM608966.pdf\" xlink:type=\"simple\">https:\/\/www.fda.gov\/downloads\/Drugs\/DevelopmentApprovalProcess\/DrugDevelopmentToolsQualificationProgram\/BiomarkerQualificationProgram\/UCM608966.pdf<\/ext-link>"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T22:04:01Z","timestamp":1663279441000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002780"}},"subtitle":[],"editor":[{"given":"Mark","family":"Hatherill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002780","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]}}}